People · Operator
Named in public records as an officer, director or promoter · active 2009–2020 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Heron Therapeutics, Inc. /De/ | — | Biotechnology | Series C | $117.2M | $382.4M | 2009 |
| Valeritas Inc | — | Other Technology | Series C | $106.5M | $689.9M | 2014 |
| Apollo Endosurgery, Inc. | — | Biotechnology | Series B | $62.4M | $969.1M | 2019 |
John Barr at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Barr on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Ryan | 1 | 17 |
| CRAIG JOHNSON | 1 | 16 |
| Todd Foley | 1 | 12 |
| Ittai Harel | 1 | 6 |
| Robert Zerbe | 1 | 5 |
| Daniel Pelak | 1 | 5 |
| Rick Anderson | 1 | 4 |
| Paul Goddard | 1 | 4 |
| Sean Traynor | 1 | 3 |
| Kevin Kotler | 1 | 3 |
| Vaughn Kailian | 1 | 3 |
| Daniel L. Kisner | 1 | 3 |
| Michael Bigham | 1 | 3 |
| Kristine Peterson | 1 | 3 |
| Kevin Tang | 1 | 3 |
| STEFANIE CAVANAUGH | 1 | 3 |
| JOHN B. WHELAN | 1 | 2 |
| Paul Queally | 1 | 2 |
| Matthew S. Crawford | 1 | 2 |
| James Dentzer | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.